2008
DOI: 10.1016/j.ajo.2007.09.023
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. I. Findings before the Era of Highly Active Antiretroviral Therapy (1988 to 1994)

Abstract: Lesion location and drug use that affects virus activity may influence the severity of lesion border opacity, a measure that may be more useful than lesion type in future clinical studies of CMV retinitis. In contrast to earlier concepts, CMV retinitis does not seem to be a fovea-sparing disease. Findings in this study can serve as a reference for investigations into possible changes in CMV retinitis since the introduction of HAART.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
54
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(56 citation statements)
references
References 36 publications
1
54
0
1
Order By: Relevance
“…However, lesion location may be confounded by lesion size because large lesions are more likely to encompass more than one zone. 27 The association between anterior lesion location and retinal detachment found in this study did not persist after adjusting for lesion size, suggesting that the size of a retinitis lesion is a stronger risk factor for retinal detachment than is anterior extent of the lesion, at least in this population.…”
Section: Discussionmentioning
confidence: 48%
See 1 more Smart Citation
“…However, lesion location may be confounded by lesion size because large lesions are more likely to encompass more than one zone. 27 The association between anterior lesion location and retinal detachment found in this study did not persist after adjusting for lesion size, suggesting that the size of a retinitis lesion is a stronger risk factor for retinal detachment than is anterior extent of the lesion, at least in this population.…”
Section: Discussionmentioning
confidence: 48%
“…In this setting with limited capacity for screening, bilateral disease is likely a marker of the duration of untreated CMV retinitis, as well as an indication of the amount of time that a patient has been severely immunocompromised. 27 Although we did not find the time between diagnosis of CMV retinitis and retinal detachment to be predictive of retinal detachment in the multivariate analysis, this variable does not capture how long the patient had CMV retinitis prior to being diagnosed. In this Thai setting, patients likely develop CMV retinitis several months before they present to the ophthalmologist.…”
Section: Discussionmentioning
confidence: 70%
“…Classically, the disease is characterized by minimal intraocular inflammation due to the deep immunodeficiency of these patients, in contrast to the severe inflammation associated with viral retinal necrosis syndromes in the immunocompetent [10 ]. Soon after the advent of HAART, enhanced inflammatory reactions, predominantly in the vitreous cavity as seen in Fig.…”
Section: Immune Recovery Uveitismentioning
confidence: 91%
“…Patients with CMV retinitis presented a similar immunological profile as observed in the era before HAART. At that time patients had low CD4+ T-cell counts and elevated HIV viral loads (4,12) , although patients receiving HAART showed a broader range of CD4+ count, including values of more than 50 cells/µl (4) . As in other studies, most of these patients have longstanding AIDS, had received HAART and are intolerant or non responsive to this therapy (4)(5)(6) .…”
Section: Discussionmentioning
confidence: 99%
“…Patients with CD4+ lymphocytes count below 100 cells/µl and especially patients with CD4+ count 50 cells/µl or less have a proven increased risk of developing the retinitis (11) . Before HAART, CMV disease was characteristically a relapsing retinitis associated with progressive visual loss despite the repeated specific anti-CMV therapy (7,12) . As a consequence of HAART, safe discontinuation of maintenance treatment with anti-CMV medication is possible in patients who experience immune reconstitution (13)(14) .…”
Section: Introductionmentioning
confidence: 99%